FOXO3 and chronic kidney disease: Total Foxo3a expression remained unchanged in IR-induced AKI (48 h) and CKD (4 weeks) models (Fig. 7A–D), but western blot analysis revealed increased Foxo3a phosphorylation in both settings (Fig. 7A–H).